L' impatto di COVID19 sulla broncopneumopatia cronica ostruttiva
Main Article Content
Abstract
We report a case of a 50 years old man with typical clinical picture of SARS-CoV-2 infection that was admitted to Emergency Department at Assisi Hospital.
We discuss the clinical scenario, the clinical course of the patient and the therapy that was administered in Intensive Care Unit.
Downloads
Article Details
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
References
https://www.mise.gov.it/images/stories/normativa/DM-MiSE-25-03-20.pdf (accessed March 26, 2020).
Istituto Superiore di Sanità. Sorveglianza integrata COVID-19 in Italia. March 16, 2020.
https://www.epicentro.iss.it/coronavirus/bollettino/Infografica_26marzo%20ITA.pdf (accessed March 26, 2020).
https://www.cebm.net/covid-19/global-covid-19-case-fatality-rates/ (accessed 26 March, 2020).
Onder G, Rezza G, Brusaferro S. Case-Fatality Rate and Characteristics of Patients Dying in Relation to COVID-19 in Italy.
JAMA. 2020 Mar 23. doi: 10.1001/jama.2020.4683.
Baud D, Qi X, Nielsen-Saines K, Musso D, Pomar L, Favre G Real estimates of mortality following COVID-19 infection.
Lancet Infect Dis. 2020 Mar 12. pii: S1473-3099(20)30195-X. doi: 10.1016/S1473-3099(20)30195-X.
Zhang L, Liu Y. Potential interventions for novel coronavirus in China: A systematic review. Journal of medical virology 2020.
Luo P, Liu Y, Qiu L, Liu X, Liu D, Li J. J Med Virol. 2020 Apr 6. doi: 10.1002/jmv.25801. Tocilizumab treatment in COVID-19:
a single center experience.